10 stories tagged with #oncology, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Oncology"
Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery Transcript
Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery April 30, 2026 8:30 AM EDTCompany...…
Nuvalent: A Precision Oncology Platform With Two Near-Term Shots On Goal
Nuvalent is positioned as a high-quality late-stage biotech with two near-commercial precision oncology assets. Read more on NUVL stock here.…
Cullinan Therapeutics: Cash-Rich With A Major 2027 FDA Catalyst
Cullinan Therapeutics, Inc. has a cash-rich balance sheet and no financial debt while trading at a reasonable valuation. Read more on CGEM stock here.…
NovoCure Limited 2026 Q1 - Results - Earnings Call Presentation
2026-04-30. The following slide deck was published by NovoCure Limited in conjunction with their 2026 Q1 earnings call.…
First-ever 3D view shows how killer T cells destroy cancer
The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized contact zone that lets them destroy dangerous cells without h…
Form 13G Coherus Oncology For: 29 April
LeonaBio, Inc. (LONA) Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene Transcript
LeonaBio, Inc. (LONA) Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, 2026...…
Aktis Oncology: 'Buy' Based On Radiotherapeutic Isotope Design For Broad Targeting
Aktis Oncology (AKTS) stock is given a "Buy" rating, driven by its innovative miniprotein radioconjugates targeting Nectin-4 and B7-H3 solid tumors. Read the full analysis here.…